Cite
HARVARD Citation
Clowse, M. et al. (2017). Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials. Arthritis & rheumatology. 69 (2), pp. 362-375. [Online].